All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
Feminox 40mg Injection PFS_204272 (1)
Feminox 40mg Injection PFS_204272 (2)
Feminox 40mg Injection PFS_204272 (1)
37% Off

Feminox 40mg Injection PFS

Prescription Required

Salt Composition : Enoxaparin

Manufacturer : INTAS PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: 470.33
Price : 295
You Save : 175 (37%)

1 Prefilled Syringe(s) Of 0.4ml

Pincode
Delivery By -

Introduction to Feminox 40mg Injection Pfs

Feminox 40mg Injection PFS is an anticoagulant drug belonging to the category of low molecular weight heparin (LMWH). It contains the active ingredient Enoxaparin. It is used to treat severe blood clots. This drug also prevents the occurrence of deep vein thrombosis in abdominal surgery, hip replacement surgery, knee replacement surgery, and in people with severe movement restrictions. This injection prevents further heart complications in patients with unstable angina and non-Q wave myocardial infarction.

Feminox 40mg Injection PFS is not recommended for patients with active bleeding, hypersensitivity, or allergies to the active compound, as well as those with a history of heparin-induced thrombocytopenia before taking Feminox 40mg Injection PFS. Tell your physician if you are allergic to Enoxaparin, heparin, benzyl alcohol, or pork products. 

Your healthcare provider will regularly monitor you for signs of bleeding. Inform your healthcare practitioner if you are diagnosed with kidney problems. It is not recommended for use in children and adolescents below 18 years. 

Feminox 40mg Injection PFS is not recommended if you undergo procedures like neuraxial anaesthesia or spinal puncture. It is recommended to monitor older adults and patients with low weight for increased risk of bleeding.

Tell your physician if you suspect pregnancy, breastfeeding, or planning to have a baby. Feminox 40mg Injection PFS may increase the chance of bleeding in pregnant women with artificial heart valves, and hence, close monitoring must be done. 

Consult your doctor for more advice before starting Feminox 40mg Injection PFS medication. It is recommended not to take any hemostatic drugs unless absolutely necessary.  It is needed to inform your physician about all the drugs you are taking, including herbal and vitamin supplements.


Uses of Feminox 40mg Injection Pfs

Feminox 40mg Injection PFS is used in the treatment of the following:

  • Deep vein thrombosis
  • Prophylaxis of venous thrombo-embolism
  • Unstable angina
  • ST-segment Elevation Myocardial Infarction (STEMI)
  • Prevention of blood clots during surgeries

Therapeutic Effects of Feminox 40mg Injection Pfs

Feminox 40mg Injection PFS binds to the antithrombin to form a complex. Antithrombin is a protein that blocks the formation of abnormal blood clots. This drug mainly prevents the activation of factor Xa, eventually preventing clot formation. It is commonly used for the prevention and treatment of conditions associated with increased risk of blood clots.


Interaction of Feminox 40mg Injection Pfs with other drugs

Some medicinal products that affect haemostasis should be discontinued before starting Feminox 40mg Injection PFS therapy unless absolutely necessary. If a combination is required, Feminox 40mg Injection PFS should be used with careful clinical and laboratory monitoring. 

These products include systemic salicylates, acetylsalicylic acid at anti-inflammatory doses, NSAIDs like ketorolac, other thrombolytics such as alteplase, reteplase, streptokinase, tenecteplase, urokinase, and other anticoagulants. 

Always inform your doctor about any medicines or supplements you are taking, as they may interact with Feminox 40mg Injection PFS.


More Information about Feminox 40mg Injection Pfs

  • Store Feminox 40mg Injection PFS below 25 °C.
  • Do not freeze
  • Keep it out of reach from children.
  • Protect them from light and moisture

How to consume Feminox 40mg Injection Pfs

Feminox 40mg Injection PFS will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.


Safety Advices for Feminox 40mg Injection Pfs

Image Not Available  

Pregnancy

  

Before beginning therapy with Feminox 40mg Injection PFS, tell your doctor if you are pregnant, suspect you are pregnant, or are planning to become pregnant. It is not known that Feminox 40mg Injection PFS interferes with pregnancy.

Image Not Available  

Breast Feeding

  

It is unknown if Feminox 40mg Injection PFS is excreted unaltered in breast milk. Please consult your doctor before breastfeeding. 

Image Not Available  

Lungs

  

It is unknown whether Feminox 40mg Injection PFS is safe for patients with lung problems. Consult your doctor if you have lung disease before starting the treatment.

Image Not Available  

Liver

  

Inform your doctor if you have liver disease because of Feminox 40mg Injection PFS should be used cautiously with a liver condition.

Image Not Available  

Alcohol

  

It is unknown if consuming alcoholic beverages while taking Feminox 40mg Injection PFS is safe. Please consult with your physician.

Image Not Available  

Driving

  

It is safe to travel, drive a car, or operate heavy machinery after receiving Feminox 40mg Injection PFS. Feminox 40mg Injection PFS does not impair alertness or coordination.


Side Effects of Feminox 40mg Injection Pfs

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious side effects of Feminox 40mg Injection PFS are:

  • Severe allergic reactions (swelling of lips, tongue, or throat, difficulty breathing, or swallowing)
  • Too much bleeding (weakness, being pale, dizziness with headache, or unexplained swelling)
  • Blockage of blood vessels (pain, redness, or swelling in the legs, or coughing up blood)
  • Rash of dark red spots under the skin

Common side effects of Feminox 40mg Injection PFS are:

  • Bleeding
  • Bruising more easily
  • Low blood cell counts
  • Headache
  • Itchy red skin
  • Edema
  • Pain at the injection site
  • Pink patches on the skin

Word of Advice

Feminox 40mg Injection PFS can cause bleeding and many undesirable side effects; hence, it is advised to get adequate rest during the treatment. Eat a well-balanced diet. Apply a cool compress at the injection site to reduce pain and irritation. Feminox 40mg Injection PFS should not be stopped suddenly without first talking to your doctor because doing so may raise your risk of blood clots. 

Aspirin and other non-steroidal anti-inflammatory medicines (NSAIDs) may increase the risk of bleeding when combined with Feminox 40mg Injection PFS, so it is not recommended to take them without first talking to your doctor. Keep away from activities that put you at higher risk of bleeding or getting hurt, like contact sports and activities. 

Foods high in Vitamin K may have an impact on blood clotting and may interfere with the way anticoagulant drugs like Feminox 40mg Injection PFS. It is recommended to eat leafy green vegetables, asparagus, Brussels sprouts and soybean oil in moderation. It is advised to monitor your platelet count regularly.


FAQs

Q 1. Who should not take Feminox 40mg Injection PFS?

Feminox 40mg Injection PFS is not recommended for people suffering from active major bleeding or a history of hypersensitivity to Feminox 40mg Injection PFS, heparin, Benzyl alcohol, or pork products. This drug is also not advised for people with a history of heparin-induced thrombocytopenia in the past hundred days.

Q 2. How should Feminox 40mg Injection PFS be stored?

Feminox 40mg Injection PFS should be stored at room temperature (between 68°F to 77°F or 20°C to 25°C) away from light and moisture. It should be kept out of the reach of children and not be frozen. Unused portions of Feminox 40mg Injection PFS solution should be discarded according to the manufacturer's instructions.

Q 3. When should you report to the doctor while using Feminox 40mg Injection PFS?

Contact your physician directly if you experience severe allergic reactions like the spelling of lips, tongue, throat, difficulty breathing or swallowing, unexplained swelling, painful Rash, chest pain, or blood in the cough during the treatment with Feminox 40mg Injection PFS.

Q 4. How long should Feminox 40mg Injection PFS treatment continue?

The duration of Feminox 40mg Injection PFS treatment depends on the underlying condition being treated, the risk of clotting, and individual patient factors. Treatment may be short-term (e.g., during hospitalisation or surgical procedures) or long-term for chronic conditions such as DVT or PE.

Q 5. What are the common side effects of Feminox 40mg Injection PFS?

Common side effects of Feminox 40mg Injection PFS may include bleeding or bruising at the injection site, nosebleeds, nausea, headache, and itching. Serious side effects such as severe bleeding or allergic reactions are rare but may occur.

Q 6. What should I not take with Feminox 40mg Injection PFS?

When taking Feminox 40mg Injection PFS, it's important to avoid certain medications, supplements, and activities that may increase the risk of bleeding or interact with the anticoagulant effects of Feminox 40mg Injection PFS includes other anticoagulants, non-steroidal anti-inflammatory drugs, and anti-platelets.


Fact Box of Feminox 40mg Injection Pfs

Molecule Name: Enoxaparin

 

Therapeutic class:  Anticoagulant
Pharmacological class: Low molecular weight heparin (LMWH)

Indications: 

Treat and prevent blood clot


References

1. Rovi Pharma Industrial ServicesElectronic Medicines Compendium (EMC), [Revised on Apr 2022], [Accessed on March 2024],https://www.medicines.org.uk/emc/files/pil.9331.pdf 

2. Sanofi, [Revised on Apr 2022] [Accessed on March 2024], https://products.sanofi.us/lovenox/lovenox.pdf

3. Sanofi India Limited, Central Drugs Standard Control Organisation (CDSCO), [Revised on Dec 2018], [Accessed on March 2024], https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadPrescribingInfo/1CLEXANE-SANOFI.pdf 

4. KD Tripathi, Essentials of Medical Pharmacology, Drugs Affecting Coagulation, Bleeding and Thrombosis, 8th Edition, 2019, 659-681.

5. https://www.ema.europa.eu/en/documents/product-information/inhixa-epar-product-information_en.pdf


Disclaimer

MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.